MC38-hFOLR1/hCD47(2)
品系基本信息
驗(yàn)證數(shù)據(jù)
Fig1. Analysis of hFOLR1 and hCD47 expression in in vitro cultured MC38-hFOLR1/hCD47 cells by FACS.
Fig2. In vivo validation of MC38-hFOLR1/hCD47 in C57BL/6 mice.?C57BL/6 mice were inoculated with MC38-hFOLR1/hCD47 subcutaneously at 1×106 cells /mouse inoculum for tumor development.
Fig3. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice.?The tumors were collected at day 25 post tumor cell inoculation.
Fig4. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice. The tumors were collected at day 35 post tumor cell inoculation.
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見(jiàn)的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
